COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 6: Articles 51-60  | Next

Ecological Cascades and Future Hantavirus Spillover Risk in a Changing Climate
Pandit, P., Jian, A. H., Gupta, A., Kulkarni, P.
10.64898/2026.07.13.738318 — Posted: 2026-07-14
Three phylogenetic metrics are compatible with natural evolution of the earliest SARS-CoV-2 sequence
Lorenzi, J.-N., Graner, F., Bigot, T., Decroly, E., Courtier-Orgogozo, V., Achaz, G.
10.64898/2026.07.08.737272 — Posted: 2026-07-14
SARS-CoV-2 ORF9b exploits mitochondrial recruitment to TOMM70 for proteasomal protection and tunes inflammatory remodeling during lung infection
Zhao, Y., Kergoat, L., Dias de Melo, G., Larrous, F., Drumont, G., Hernandez Camacho, J. D., Vimont, E., Le Seac'h, E., Saunders, N., Kaechele, M., Kornobis, E., Giai Gianetto, Q., Matondo, M., Tardieux, I., Schwartz, O., Bourhy, H., Wai, T.
10.64898/2026.07.13.738231 — Posted: 2026-07-14
AI-Driven Discovery and BSL-4 Validation of Cross-Filovirus Ebola-Marburg Inhibitors and their Synergistic Combinations
Martin, H.-J., Scotti, M. T., Jain, S., McMullan, L., Chatterjee, P., Melo-Filho, C., Caza, M., Tropsha, A., Lin, H., Flint, M., Lee, E. M., Lo, M. K., Zakharov, A. V., Muratov, E.
10.64898/2026.07.09.737586 — Posted: 2026-07-10
A Variant-Resistant Linear Epitope in the SARS-CoV-2 Nucleocapsid Protein for Antigen Detection
Su, Z., Guo, J., Zhou, H., Ni, J., Cao, Y., Peng, L., Shao, M., Li, H.
10.64898/2026.07.10.737673 — Posted: 2026-07-10
Molecular-level analysis of serum IgG repertoires in COVID-19-vaccinated people with cystic fibrosis identifies abundant convergent antibodies
Lee, J., Ionov, S., Connor, R. I., Curtis, N. C., Shin, S. M., Kim, B. H., Koehne, N., Park, J.-Y., Ashare, A., Wright, P. F.
10.64898/2026.07.08.737356 — Posted: 2026-07-10
Mutational bias shapes protein evolution across RNA viruses
Efimenko, B., Voronka, A., Skripskaya, V., Timonina, V., Agranovsky, A., Yurov, V., Khrapko, K., Fellay, J., Gunbin, K., Popadin, K.
10.64898/2026.07.07.737047 — Posted: 2026-07-09
Ebola virus exploits host lncRNA LINC01740 to enhance ATF3 and suppress antiviral immune responses
Shtanko, O., Gunturu, T., Gopal, A., Djurkovic-Lopez, M., Nguyen, H., Jayakumar, S., DSilva, A. L., Thomas, A., Kulkarni, S.
10.64898/2026.07.06.731958 — Posted: 2026-07-09
Bulk and single-cell transcriptomics reveal elevated endogenous retrovirus expression linked to immunopathology in severe COVID-19.
Wang, B., Deckers, T., Liu, E., Tokuyama, M.
10.64898/2026.07.08.737320 — Posted: 2026-07-09
Coordinated expansion of CD163⁺ monocytes and immature CD177⁺ neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy
Chour, T., Poole, N., MacMillian, H., Burleigh, K., Glass, D. R., Liang, E. C., Basom, R., Webb-Robertson, B.-J., Stratton, K., Gratz, D., Long, A. N., Elz, A. E., Huang, J. J., Hirayama, A., Riddell, S. R., Gauthier, J., Gustafson, H. H., Newell, E. W., Simon, S.
10.64898/2026.07.07.737099 — Posted: 2026-07-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).